TNF and melanoma: The most advanced clinical studies include its use in combination with L19-TNF for the treatment of fully resectable stage IIIB, C melanoma [NCT02938299] and in combination with stereotactic ablative radiotherapy for the treatment of oligometastatic tumors [NCT03705403].